PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
AXL 633 Target Disease Mesothelioma 11,198 5 0.00 -1.00 0.01 0.61
Hypoxia-Inducible Factor 1-Alpha 923 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.53
Hypoxia-Inducible Factor 1-Alpha 923 Target Target BDNF 11,163 2 0.00 -1.00 0.00 0.57
Hypoxia-Inducible Factor 1-Alpha 923 Target Target BRAF 4,766 3 0.00 -1.00 0.00 0.61
Hypoxia-Inducible Factor 1-Alpha 923 Target Disease Lung Cancer 91,416 21 0.00 -0.99 0.02 0.58
Hypoxia-Inducible Factor 1-Alpha 923 Target Target CD34 24,598 25 0.01 -0.99 0.03 0.63
Hypoxia-Inducible Factor 1-Alpha 923 Target Disease Ulcers 45,142 4 0.00 -1.00 0.00 0.55
Hypoxia-Inducible Factor 1-Alpha 923 Target Disease Inflammation 252,734 41 0.00 -0.98 0.04 0.57
Hypoxia-Inducible Factor 1-Alpha 923 Target Target Equilibrative Nucleoside Transporter 1 211 1 0.00 -1.00 0.00 0.66
Hypoxia-Inducible Factor 1-Alpha 923 Target Target Galectin-1 1,131 1 0.00 -1.00 0.00 0.62
Hypoxia-Inducible Factor 1-Alpha 923 Target Drug Doxorubicin 28,033 11 0.00 -0.99 0.01 0.60
Hypoxia-Inducible Factor 1-Alpha 923 Target Disease Liver Disease 49,817 5 0.00 -1.00 0.01 0.56
Hypoxia-Inducible Factor 1-Alpha 923 Target Disease Heart Disease 118,291 8 0.00 -1.00 0.01 0.55
Hypoxia-Inducible Factor 1-Alpha 923 Target Target CXCL2 750 1 0.00 -1.00 0.00 0.63
Hypoxia-Inducible Factor 1-Alpha 923 Target Target CYR61 539 1 0.00 -1.00 0.00 0.64
Hypoxia-Inducible Factor 1-Alpha 923 Target Disease Erythema 22,182 1 0.00 -1.00 0.00 0.54
Hypoxia-Inducible Factor 1-Alpha 923 Target Disease Glioblastoma 17,933 10 0.00 -0.99 0.01 0.61
Hypoxia-Inducible Factor 1-Alpha 923 Target Disease Mesothelioma 11,198 2 0.00 -1.00 0.00 0.57
ERBB3 1,154 Target Target BDNF 11,163 2 0.00 -1.00 0.00 0.57
ERBB3 1,154 Target Target BRAF 4,766 10 0.00 -0.99 0.01 0.65
ERBB3 1,154 Target Disease Lung Cancer 91,416 49 0.00 -0.98 0.04 0.60
ERBB3 1,154 Target Target CD34 24,598 2 0.00 -1.00 0.00 0.55
ERBB3 1,154 Target Target beta-Cellulin 17 3 0.02 -0.91 0.18 0.72
ERBB3 1,154 Target Disease Inflammation 252,734 12 0.00 -0.99 0.01 0.53
ERBB3 1,154 Target Target Activin A 2,048 1 0.00 -1.00 0.00 0.60
ERBB3 1,154 Target Drug Doxorubicin 28,033 4 0.00 -1.00 0.00 0.56
ERBB3 1,154 Target Disease Heart Disease 118,291 2 0.00 -1.00 0.00 0.51
ERBB3 1,154 Target Disease Infertility 35,448 1 0.00 -1.00 0.00 0.52
ERBB3 1,154 Target Target aFGF 899 1 0.00 -1.00 0.00 0.62
ERBB3 1,154 Target Disease Glioblastoma 17,933 14 0.00 -0.99 0.01 0.61
ERBB3 1,154 Target Disease Mesothelioma 11,198 3 0.00 -1.00 0.00 0.58
Complement Component C1q 167 Target Target CD34 24,598 1 0.00 -1.00 0.01 0.57
Complement Component C1q 167 Target Disease Inflammation 252,734 9 0.00 -0.97 0.05 0.56
Complement Component C1q 167 Target Disease Urticaria 10,717 1 0.00 -1.00 0.01 0.59
BDNF 11,163 Target Target D(2) Dopamine Receptor 1,559 8 0.00 -1.00 0.01 0.60
BDNF 11,163 Target Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.62
BDNF 11,163 Target Disease Lung Cancer 91,416 10 0.00 -1.00 0.00 0.50
BDNF 11,163 Target Target CD34 24,598 14 0.00 -1.00 0.00 0.55
BDNF 11,163 Target Disease Bipolar Affective Disorder 1,690 11 0.00 -1.00 0.01 0.61
BDNF 11,163 Target Disease Hypothyroidism 23,397 22 0.00 -1.00 0.00 0.57
BDNF 11,163 Target Target BMP-2 3,889 7 0.00 -1.00 0.00 0.58
BDNF 11,163 Target Disease Seizures 66,465 183 0.01 -0.99 0.02 0.61
BDNF 11,163 Target Target Cardiotrophin-1 351 8 0.00 -0.99 0.02 0.63
BDNF 11,163 Target Disease Ulcers 45,142 5 0.00 -1.00 0.00 0.50
BDNF 11,163 Target Drug Doxycycline 9,324 9 0.00 -1.00 0.00 0.57
BDNF 11,163 Target Target CXCL10 2,386 2 0.00 -1.00 0.00 0.55
BDNF 11,163 Target Target Glutamate Receptor 1 352 4 0.00 -0.99 0.01 0.61
BDNF 11,163 Target Drug Kaempferol 2,992 1 0.00 -1.00 0.00 0.53
BDNF 11,163 Target Disease Inflammation 252,734 287 0.01 -0.99 0.03 0.57
BDNF 11,163 Target Target Activin A 2,048 5 0.00 -1.00 0.00 0.58
BDNF 11,163 Target Target Galectin-1 1,131 4 0.00 -1.00 0.00 0.59
BDNF 11,163 Target Drug Doxorubicin 28,033 5 0.00 -1.00 0.00 0.51
BDNF 11,163 Target Disease Liver Disease 49,817 5 0.00 -1.00 0.00 0.50
BDNF 11,163 Target Disease Heart Disease 118,291 3 0.00 -1.00 0.00 0.46
BDNF 11,163 Target Disease Contraception 21,402 2 0.00 -1.00 0.00 0.50
BDNF 11,163 Target Target CCL1 220 1 0.00 -1.00 0.00 0.58
BDNF 11,163 Target Target CXCL2 750 2 0.00 -1.00 0.00 0.58
BDNF 11,163 Target Target CYR61 539 1 0.00 -1.00 0.00 0.57
BDNF 11,163 Target Disease Anxiety Disorder 8,985 22 0.00 -1.00 0.00 0.60
BDNF 11,163 Target Disease Erythema 22,182 2 0.00 -1.00 0.00 0.49
BDNF 11,163 Target Disease Infertility 35,448 8 0.00 -1.00 0.00 0.52
BDNF 11,163 Target Disease Malnutrition 27,452 8 0.00 -1.00 0.00 0.53
BDNF 11,163 Target Target aFGF 899 21 0.01 -0.99 0.02 0.65
BDNF 11,163 Target Disease Glioblastoma 17,933 3 0.00 -1.00 0.00 0.51
BDNF 11,163 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.49
BDNF 11,163 Target Disease Schizoaffective Disorder 3,104 13 0.00 -1.00 0.00 0.61
BDNF 11,163 Target Disease Urticaria 10,717 1 0.00 -1.00 0.00 0.50
D(2) Dopamine Receptor 1,559 Target Disease Lung Cancer 91,416 2 0.00 -1.00 0.00 0.51
D(2) Dopamine Receptor 1,559 Target Disease Seizures 66,465 10 0.00 -1.00 0.01 0.56
D(2) Dopamine Receptor 1,559 Target Disease Ulcers 45,142 1 0.00 -1.00 0.00 0.51
D(2) Dopamine Receptor 1,559 Target Drug Doxycycline 9,324 1 0.00 -1.00 0.00 0.55
D(2) Dopamine Receptor 1,559 Target Target Glutamate Receptor 1 352 1 0.00 -1.00 0.00 0.63
D(2) Dopamine Receptor 1,559 Target Disease Inflammation 252,734 3 0.00 -1.00 0.00 0.49
D(2) Dopamine Receptor 1,559 Target Drug Doxorubicin 28,033 1 0.00 -1.00 0.00 0.52
D(2) Dopamine Receptor 1,559 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.00 0.49
D(2) Dopamine Receptor 1,559 Target Disease Anxiety Disorder 8,985 1 0.00 -1.00 0.00 0.55
D(2) Dopamine Receptor 1,559 Target Disease Malnutrition 27,452 1 0.00 -1.00 0.00 0.52
BRAF 4,766 Target Disease Lung Cancer 91,416 174 0.01 -0.98 0.04 0.61
BRAF 4,766 Target Target CD34 24,598 14 0.00 -1.00 0.00 0.57
BRAF 4,766 Target Disease Nephrotic Syndrome 14,681 2 0.00 -1.00 0.00 0.53
BRAF 4,766 Target Disease Skin Rash 3,684 12 0.00 -1.00 0.00 0.63
BRAF 4,766 Target Disease Hypothyroidism 23,397 7 0.00 -1.00 0.00 0.55
BRAF 4,766 Target Disease Seizures 66,465 7 0.00 -1.00 0.00 0.52
BRAF 4,766 Target Disease Ovarian Cyst 1,959 2 0.00 -1.00 0.00 0.58
BRAF 4,766 Target Disease Ulcers 45,142 1 0.00 -1.00 0.00 0.48
BRAF 4,766 Target Drug Doxycycline 9,324 11 0.00 -1.00 0.00 0.60
BRAF 4,766 Target Target CXCL10 2,386 2 0.00 -1.00 0.00 0.58
BRAF 4,766 Target Disease Inflammation 252,734 29 0.00 -1.00 0.01 0.52
BRAF 4,766 Target Drug Doxorubicin 28,033 6 0.00 -1.00 0.00 0.54
BRAF 4,766 Target Disease Liver Disease 49,817 2 0.00 -1.00 0.00 0.50
BRAF 4,766 Target Disease Heart Disease 118,291 6 0.00 -1.00 0.00 0.50
BRAF 4,766 Target Disease Contraception 21,402 1 0.00 -1.00 0.00 0.50
BRAF 4,766 Target Disease Vertigo 10,084 1 0.00 -1.00 0.00 0.52
BRAF 4,766 Target Target CCL21 808 1 0.00 -1.00 0.00 0.58
BRAF 4,766 Target Disease Erythema 22,182 7 0.00 -1.00 0.00 0.55
BRAF 4,766 Target Disease Infertility 35,448 1 0.00 -1.00 0.00 0.49
BRAF 4,766 Target Disease Glioblastoma 17,933 26 0.00 -1.00 0.01 0.60
BRAF 4,766 Target Disease Mesothelioma 11,198 7 0.00 -1.00 0.00 0.57
BRAF 4,766 Target Disease Warts 5,574 1 0.00 -1.00 0.00 0.54
BRAF 4,766 Target Target Cytokeratin 18 1,108 1 0.00 -1.00 0.00 0.57